Clinical Study of Endocardial Myocardial Biopsy
Phase 4
Recruiting
- Conditions
- MyocarditisCardiac TumorHeart FailureCardiomyopathiesEndocardiomyocardial Biopsy
- Interventions
- Procedure: Endocardiomyocardial biopsy
- Registration Number
- NCT05718128
- Lead Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University
- Brief Summary
In this study, patients with endocardial myocardial biopsy were selected to observe the safety of the operation, and pathological examination was performed. If necessary, special tests such as viral examination, mass spectrometry and molecular biology were performed to confirm the diagnosis, and follow-up was performed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Patients with no gender restriction, age 18-80 years old, receiving endocardial myocardial biopsy in the Second Affiliated Hospital of Zhejiang University School of Medicine;
- Patients with myocarditis, cardiomyopathy, heart failure and cardiac tumor of unknown clinical cause;
- Have the ability to understand the test, can cooperate with investigators.
Exclusion Criteria
- Unable to understand or unwilling to fill in informed consent forms or follow visitors.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Biopsy Endocardiomyocardial biopsy patients
- Primary Outcome Measures
Name Time Method Incidence of MACE-4 10 year incidences of MACE-4(cardiovascular death, myocardial infarction, stroke and hospitalized unstable angina)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
🇨🇳Hangzhou, Zhejiang, China